12、3 trials, enrolling 700 patients that reported the composite end point of all-cause mortality, reinfarction, and HF, rescue PCI was associated with a significant RR reduction of 28% (RR 0.72; 95% CI, 0.59-0.88; P=.001)RESCUE I 研究结果研究结果N=2433Am Heart J 2000;139:1046 - 53...
stemi介入时机的选择课件 stemi介入时机的选择 AMI与冠状动脉闭塞 DewoodNEJM1980;303:897 87.3 85.3 68.4 64.9 0-4 4-6 6-12 12-24 时间(h)冠脉闭塞（%）stemi介入时机的选择 Call120 Admission Cath.lab.Ambulance
Patients in minority communities experienced a 1.8–percentage point smaller improvement in access (95% CI, −2.8 to −0.8 percentage points; P < .001), or 28.9% smaller, compared with those in nonminority communities when both were exposed to regionalization. Regionalization was associated...
The hypothesis was: compared to UFH, adjunctive antithrombin therapy with ENOX reduces the composite end point of all-cause mortality or non-fatal reMI within 30 days in patients with STEMI who are eligible to receive fibrinolytic therapy. 这是主要终点的结果:30天时,与普通肝素组相比,依诺肝素组...
目的是恢复心肌的血流灌注、减少心肌坏死,改善预后;最有效的方法是开通梗死相关血管 - 再灌注治疗 文档格式: .ppt 文档大小: 3.13M 文档页数: 32页 顶/踩数: 6/0 收藏人数: 11 评论次数: 0 文档热度: 文档分类: 医学/心理学--内科学 文档标签: ...
Primary end-point of the study was the occurrence of TRA failure and need to crossover to another access site to finish the procedure. RESULTS. From the STEMI population in this period the female group had 1326 PPCI treated patients and the male group 3766 patients. The female group of ...
从2017ESC新指南看STEMI患者的综合管理 2017ESCSTEMI指南的重要更新 推荐变化 2017新推荐 桡动脉入路 MATRIX DES优于BMS EXAMINATION,COMFORTABLE-AMI,NORSTENT 完全血运重建 PRAMI,DANAMI-3-PRIMULTI,CVLPRIT,Compare-Acute 血栓抽吸 TOTAL,TASTE 比伐卢定 MATRIX,HEAT-PPCI 依诺肝素 ATOLL,Meta-analysis 早出院 Small...
prevalence, clinical characteristics, response to therapy and outcomes. platelets. 2021;15:1–8. https://doi.org/10.1080/09537104.2021.1915973. 14. hm garcia-garcia, ep mcfadden, a farb. academic research consortium. stand...
They point out that the COMPLETE trial, which has recently reached its enrollment target with 4,402 STEMI patients randomized to either staged complete revascularization or treatment of the culprit artery only, is powered for hard clinical outcomes. That trial “will provide the crucial safety...
N Engl J Med 1997;337:447-52. This slide shows use of enoxaparin vs UFH as adjunctive anticoagulation therapy to fibrinolysis as per the ExTRACT – TIMI 25 protocol. The hypothesis was: compared to UFH, adjunctive antithrombin therapy with ENOX reduces the composite end point of all-cause ...